Mesa Laboratories (MLAB) Aktie Kurs

Mesa Laboratories Kurs

NASDAQ·LUKKET
127,82
​
Markedet lukket

De seneste 19 år voksede Mesa Laboratoriess omsætning med 15,1 % årligt og nåede 249,13 Mio. USD. Indtjening pr. aktie er faldet med 0,2 % om året de seneste 19 år. For Mesa Laboratories er nettoavance på 2,7 % op i forhold til 1,0 % for et par år siden. Ved dagens kurs bliver direkteafkastet cirka 0,50 %. Udlodningsandelen er omkring 219 % af indtjeningen. Udbyttet er vokset med 3,4 % om året de seneste 19 år. Konsensus 12-måneders kursmål for Mesa Laboratories er 110,00 USD, cirka under kursen med 13,9 %. Af 8 analytikere anbefaler 6 køb — den samlede vurdering er Køb.

Mesa Laboratories aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Mesa Laboratories aktie og aktieanalyse

Mesa Laboratories Inc. er et amerikansk selskab, der specialiserer sig i udvikling og produktion af testudstyr og måleinstrumenter. Selskabet blev grundlagt i 1982 og har hovedkontor i Lakewood, Colorado. Forretningsmodellen fokuserer på at levere højtest kvalitetstest- og måleinstrumenter, der kan anvendes inden for forskellige brancher. Mesa Laboratories opererer inden for fire forretningsområder: medicinsk teknologi, industriel automation, fødevarer og drikkevarer samt måleteknologi. Blandt de bemærkelsesværdige produkter findes DryCal DC-Lite flowkalibrering og ATP Rapid Test til hygiejnekontrol i fødevareindustrien.

Hyppigt stillede spørgsmål om Mesa Laboratories-aktien

Mesa Laboratories Inc operates under a business model focused on providing innovative quality control solutions and support to a wide range of industries. The company specializes in manufacturing and distributing precision instruments and disposable products for the healthcare, pharmaceutical, medical, and food processing sectors. By leveraging advanced technology and expertise, Mesa Laboratories Inc helps customers ensure compliance with regulatory requirements and maintain product quality and safety. With a customer-centric approach and a commitment to continuous improvement, the company aims to empower businesses to achieve their quality control objectives efficiently and effectively.

Mesa Laboratories Inc is primarily active in the industries of pharmaceuticals, medical devices, food and beverage, and industrial manufacturing.

The main competitors of Mesa Laboratories Inc in the market include Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., and VWR International.

Mesa Laboratories Inc. is a renowned company with a rich history and background. Founded in 1982, Mesa Laboratories specializes in providing high-quality solutions for the monitoring, controlling, and validation of critical manufacturing processes. With a strong focus on data integrity and accuracy, Mesa Laboratories has established itself as a leader in the field of quality control systems. Over the years, the company has built a strong reputation for its innovative products and exceptional customer service. Mesa Laboratories continues to drive advancements in the industry, serving a wide range of sectors including pharmaceuticals, medical devices, and food processing.

Mesa Laboratories Inc has achieved several significant milestones. Over the years, the company has expanded its product offerings and customer base, becoming a renowned leader in the field. Mesa Laboratories Inc developed cutting-edge technologies and implemented innovative solutions to address customer needs effectively. Additionally, the company successfully acquired and integrated several key businesses, further enhancing its capabilities and market presence. Mesa Laboratories Inc has also received numerous accolades and industry recognitions for its exceptional performance and commitment to quality. With a strong track record of success and continuous advancements, Mesa Laboratories Inc remains a trusted and reliable provider in the stock market.

Mesa Laboratories Inc is primarily present in the United States and operates globally. With headquarters in Colorado, Mesa Laboratories Inc has a strong presence throughout its home country, serving customers in various industries including pharmaceutical, medical, food, and environmental. Apart from the United States, Mesa Laboratories Inc also has a global presence with their products and services reaching customers in countries across Europe, Asia, and Latin America. As a leading provider of quality control solutions, Mesa Laboratories Inc strives to meet the needs of their clients worldwide, offering reliable and innovative technologies to support critical processes and regulatory compliance.

Mesa Laboratories Inc represents a set of core values and corporate philosophy that reflects its commitment to excellence. With a strong focus on innovation, Mesa Laboratories Inc strives to deliver the highest quality products and services to its customers. The company values integrity, teamwork, and customer satisfaction, which form the foundation of its operations. Consequently, Mesa Laboratories Inc fosters a culture of continuous improvement and transparency, creating a strong reputation in the stock market. Investors can rely on Mesa Laboratories Inc's dedication to providing innovative solutions and maintaining strong business ethics.

Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 110,00 USD for Mesa Laboratories-aktien (median: 110,00 USD), svarende til -13,9 % i forhold til seneste kurs. Konsensus bygger på 8 analytikervurderinger.

8 analytikere vurderer i øjeblikket Mesa Laboratories-aktien: 6 anbefaler køb, 2 hold og 0 salg.

Omregnet til den aktuelle valutakurs handles Mesa Laboratories-aktien til 114,26 EUR (127,82 USD).

Mesa Laboratories-aktien (MLAB) er noteret på 3 børser, herunder: NASDAQ (MLAB), Frankfurt (MLI.F), München (MLI.MU).

The company Mesa Laboratories Inc is a publicly traded company from the USA that has been successful in the measurement and control technology industry since 1982. Mesa Laboratories offers its customers innovative products for process and environmental monitoring and validation, primarily targeting the pharmaceutical, biotech, food, aviation, and automotive industries. Mesa Laboratories' business model is based on three pillars. The first pillar is the sale of measurement and control devices for various applications. The company offers measurement and control systems for the operation of sterilization systems, cleanrooms, and environmental conditions such as temperature, humidity, and pressure. The second pillar is the provision of calibration and validation services. Mesa Laboratories is a certified service provider for calibrations, inspections, and validations of laboratory equipment and facilities. To improve efficiency and compliance, the company also offers a web-based data management platform. The third pillar of Mesa Laboratories' business model is the sale of consumables for process and environmental monitoring and validation. Products such as sterilization indicators, pharmaceutical batch process indicators, cleanroom monitoring systems, and data loggers are of great importance. Mesa Laboratories operates multiple business units to support its business model. The Biological Indicators business unit focuses on the production of products for the validation of sterilization equipment. The Environmental Monitoring and Non-Sterilization Process Monitoring business units provide solutions for controlling environmental conditions in laboratories and pharmaceutical facilities. Another important business unit of Mesa Laboratories is the divisional measurement business. Here, measurement devices and services are offered for optoelectronics, aviation, medicine, and the automotive industry. This includes products such as electronic microscopes, radiation measurement devices, and vibration meters. Mesa Laboratories is a company with a strong market position that is committed to providing its customers with excellent quality and service. An important objective of the company is customer retention and acquiring new customers through innovative technological solutions. Mesa Laboratories values sustainability, close customer relationships, and partnerships with other leading companies in the industry.

-omsætningen for Mesa Laboratories er 249,13 Mio. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

-overskuddet for Mesa Laboratories er 6,71 Mio. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for Mesa Laboratories er i øjeblikket 109,63. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Mesa Laboratories-aktien.

Pris-til-salgs-forholdet (P/S) for Mesa Laboratories er i øjeblikket 2,95. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Mesa Laboratories-aktien.

AlleAktien-kvalitetsscore for Mesa Laboratories er 2/10.

ISIN for Mesa Laboratories er US59064R1095. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Mesa Laboratories er 923604. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Mesa Laboratories er MLAB. Tickersymbolet bruges til at handle Mesa Laboratories-aktier på børsen.

Fair værdiTerminal
132,93 USD
Over-/underværdieringTerminal
Fair værdieret
Sektor
Industri
Sundhedsvæsens Udstyr & Forsyninger
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
347.461,65 USD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside mesalabs.com
Land
Valuta
USD
Børsintroduktion
29. feb. 1984
ISIN
US59064R1095
CUSIP
59064R109
SEDOL
2553814
Markedsværdi
52-ugers interval
AAQS
2 / 10
PEG-forhold
—
P/E-forhold
P/Ee 2027
12,54
P/Ee 2028
11,74
P/Ee 2029
—
P/S
P/Se
2,89
EV/EBIT
45,04
K/B-forhold
3,79
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1,97 %
Dividende
Dividendeafkast
0,50 %
Estimeret dividendeafkast
0,50 %
Udlodningsforhold
218,99 %
Dividendvækst Ø5Y
—
Dividender pr. år
4
Dividende udbetalt siden
23 år
Dividende ikke reduceret siden
23 år
Dividende øget siden
0 år
Källskat
30,00 %
Sidst opdateret 11. nov. 2026, 05.01

Mesa Laboratories Ticker

FRANKFURT · MLI.FMÜNCHEN · MLI.MUNASDAQ · MLAB

Mesa Laboratories FIGI

MLAB:US · BBG000BP3PW7MLAB:UA · BBG000BP3Q64MLAB:UC · BBG000BP3QQ2MLAB:UN · BBG000BP3R80MLAB:UP · BBG000BP3RX2MLAB:UB · BBG000BP3T68MLAB:UM · BBG000BP3V72MLAB:UX · BBG000BP3VG2MLAB:UD · BBG000BP41B2MLAB:UW · BBG000BP42Y5MLAB:UF · BBG000BP4382MLAB:VY · BBG000BP43S0